Vanderbilt University VU is a clinical research site located in Nashville, Tennessee, United States 37232.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Vanderbilt University VU has participated in 1 clinical trials.
Therapeutic areas: Glomerulosclerosis, Focal Segmental.
Sponsors: Vertex Pharmaceuticals Incorporated.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University VU has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University VU has 1 clinical trials on record. Their work covers Glomerulosclerosis, Focal Segmental.
Vanderbilt University VU has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.